Epilepsy Birth Control Registry

Description

Despite the importance of birth control to women of reproductive age, there has been little formal investigation of the safety and effectiveness of birth control methods in women with epilepsy. To remedy this, doctors from Harvard and Columbia University Medical Schools have developed a website that offers a survey to help us gain more knowledge and some educational material that will be updated regularly to provide the latest information. The ultimate goal is to develop guidelines for the selection of safe and effective birth control methods and to make sure that the best forms of birth control become available to women with epilepsy in all communities of our society. Go to www.epilepsybirthcontrolregistry.com take our survey and then catch up on the latest information about birth control for women with epilepsy.

Study Start Date

March 2010

Estimated Completion Date

December 2016

Interventions

  • Other: Non-interventional

Specialties

  • Nursing: Neurology
  • Neurology: Seizure
  • Family Medicine: Women`s Health
  • Physician Assistant: Neurology

MeSH Terms

  • Epilepsy

Study ID

Neuroendocrine Associates P.C. -- 137557

Status

Unknown

Trial ID

NCT01097837

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

1000

Sponsor

Neuroendocrine Associates P.C.

Inclusion Criteria

  • Women with Epilepsy between 18 and 47

Exclusion Criteria

  • Women without epilepsy
  • Women under 18
  • Women over 47

Gender

Female

Ages

18 Years to 47 Years

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Neuroendocrine Associates PC - Wellesley, Massachusetts 4.7 miles Kristen M Fowler MA 781-431-0277 kfowler@bidmc.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.